Patent 5,616,346 protects and is included in zero NDA.
|Title:||Non-aqueous colonic purgative formulations|
|Abstract:||Orally administered colonic purgative formulations and methods of its use for effecting partial or complete purgation of the colon in mammals, the formulations consisting of non-aqueous admixtures of monobasic, dibasic and tribasic sodium phosphates administered in tablet or capsule form in concentrations of from 0.01 to 0.85 grams per kilogram body weight. Preferred embodiments include the addition of binders, dispersants and buffers which do not adversely affect osmolality or effectiveness of the purgative formulations.|
|Inventor(s):||Aronchick; Craig A. (Penn Valley, PA)|
Patent Claim Types:|
see list of patent claims
|Composition; Dosage form; Use; Formulation;|
|Country||Document Number||Publication Date|
|World Intellectual Property Organization (WIPO)||9741838||Nov 13, 1997|
|Spain||2196149||Dec 16, 2003|
|European Patent Office (EPO)||0858326||Aug 19, 1998|
|Denmark||0858326||Jul 07, 2003|
|Germany||69627170||May 08, 2003|
|This preview shows a limited data set|
Subscribe for full access, or try a free trial
Export unavailable in trial.
Subscribe for complete access.
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors.
Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided information. There is no warranty that the information contained herein is error free. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.